Login / Signup
Jacqueline McDermott
ORCID
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 4
Top Topics
Transforming Growth Factor
Poor Prognosis
African American
Hyaluronic Acid
Top Venues
Cancer research communications
Cancer immunology research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Priyanka Hirani
,
Jacqueline McDermott
,
Vinothini Rajeeve
,
Pedro Rodriguez Cutillas
,
J Louise Jones
,
Daniel J Pennington
,
Thomas N Wight
,
Salvatore Santamaria
,
Kimberly M Alonge
,
Oliver Matthew Thomas Pearce
Versican associates with tumour immune phenotype and limits T cell trafficking via chondroitin sulfate.
Cancer research communications
(2024)
Priyanka Hirani
,
Jacqueline McDermott
,
Vinothini Rajeeve
,
Pedro Rodriguez Cutillas
,
J Louise Jones
,
Daniel J Pennington
,
Thomas N Wight
,
Salvatore Santamaria
,
Kimberly M Alonge
,
Oliver Matthew Thomas Pearce
Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate.
Cancer research communications
4 (4) (2024)
Priyanka Hirani
,
Jacqueline McDermott
,
Vinothini Rajeeve
,
Pedro Rodriguez Cutillas
,
J Louise Jones
,
Daniel J Pennington
,
Thomas N Wight
,
Salvatore Santamaria
,
Kimberly M Alonge
,
Oliver Matthew Thomas Pearce
Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate.
Cancer research communications
4 (4) (2024)
Michael-John Devlin
,
Rowan E Miller
,
Florian Laforets
,
Panoraia Kotantaki
,
Dale W Garsed
,
Rebecca S Kristeleit
,
David D L Bowtell
,
Jacqueline McDermott
,
Eleni Maniati
,
Frances R Balkwill
The Tumor Microenvironment of Clear-Cell Ovarian Cancer.
Cancer immunology research
10 (11) (2022)